Germany
Japan
United Kingdom
China
Primary Antibodies
View as table Download
USD 509.00
5 Days
USD 509.00
2 Weeks
USD 509.00
5 Days
Lactoferrin (LTF) goat polyclonal antibody, HRP
| Applications | ELISA, ID, IF, IHC, IP, WB |
| Reactivities | Human |
| Conjugation | HRP |
Lactoferrin (LTF) goat polyclonal antibody, HRP
| Applications | ELISA, ID, IF, IHC, IP, WB |
| Reactivities | Monkey |
| Conjugation | HRP |
Lactoferrin (LTF) mouse monoclonal antibody, clone NI 25, HRP
| Applications | ELISA, IF, IP, WB |
| Reactivities | Human |
| Conjugation | HRP |
Growth Hormone (GH1) mouse monoclonal antibody, clone YC8, HRP
| Applications | ELISA |
| Reactivities | Human |
| Conjugation | HRP |
USD 585.00
2 Weeks
Prostate Specific Antigen (KLK3) mouse monoclonal antibody, clone CHYH2, HRP
| Applications | ELISA, IHC |
| Reactivities | Human |
| Conjugation | HRP |
TNF alpha (TNF) mouse monoclonal antibody, clone B1E4, HRP
| Applications | ELISA |
| Reactivities | Human |
| Conjugation | HRP |
Active filters
Applications
- ELISA
Conjugates
- HRP
Families
- Secreted Protein
Filter by
Category
Target Symbol
Reactivities
Antibody Hosts
Clonalities
Assay Types
Pathways
- Cytokine-cytokine receptor interaction (6)
- NOD-like receptor signaling pathway (4)
- Antigen processing and presentation (3)
- Chemokine signaling pathway (3)
- Metabolic pathways (3)
- Fc epsilon RI signaling pathway (2)
- Hematopoietic cell lineage (2)
- Jak-STAT signaling pathway (2)
- Natural killer cell mediated cytotoxicity (2)
- Pathways in cancer (2)
- RIG-I-like receptor signaling pathway (2)
- T cell receptor signaling pathway (2)
- Toll-like receptor signaling pathway (2)
- Adipocytokine signaling pathway (1)
- Allograft rejection (1)
- Alzheimer's disease (1)
- Amyotrophic lateral sclerosis (ALS) (1)
- Apoptosis (1)
- Asthma (1)
- Bladder cancer (1)
- Dilated cardiomyopathy (1)
- Epithelial cell signaling in Helicobacter pylori infection (1)
- Graft-versus-host disease (1)
- Hypertrophic cardiomyopathy (HCM) (1)
- MAPK signaling pathway (1)
- Neuroactive ligand-receptor interaction (1)
- Prostate cancer (1)
- Systemic lupus erythematosus (1)
- TGF-beta signaling pathway (1)
- Type I diabetes mellitus (1)
- Type II diabetes mellitus (1)